Cannabis Science & Health
Canadian Cannabis Regulator Recalls Pre-Rolls Due to Incorrect Labels
The Canadian cannabis regulator has recalled 1,632 pre-roll products because they were incorrectly labeled.
Missouri Launches Its Legal Recreational Cannabis Market Early
Adult-use, recreational cannabis became legally available in Missouri on Friday, February 3 – three days earlier than planned.
Vermont Regulator Stops the Sale of Contaminated Cannabis Flower
The CCB “has verified” that multiple samples of Holland Cannabis flower tested above the action limits for myclobutanil, a chemical used as a fungicide.
Australia to Permit MDMA and Psilocybin Prescriptions
From July 1, psychiatrists in Australia will be allowed to prescribe MDMA and psilocybin as treatments for certain mental health conditions.
The Degradation Pathways of Cannabinoids and How to Manage Them – Part 2
In the second of two articles, scientists from Broughton, a regulatory consultancy currently focused on EU and UK cannabis regulation, discuss the susceptibility of cannabinoids to degrade and summarize the main degradation pathways of THC and CBD.
UK’s Health Service Can Now Prescribe Epidiolex For Tuberous Sclerosis Complex
The change comes after the National Institute for Health and Care Excellence (NICE) issued final guidance recommending its use.
Yale University to Establish a Center For Cannabis Research
The Yale Center for the Science of Cannabis and Cannabinoids will foster studies into the acute and chronic effects of cannabinoids on neuronal and mental health.
No Link Between Legal Cannabis and Psychosis Diagnoses, Study Finds
Legalizing cannabis does not affect psychosis diagnoses or the prescription of antipsychotic medicines, a new study published in JAMA Network Open has found.
Colorado Regulator Issues Warning About Moldy Flower
State regulators in Colorado have issued another health and safety notice after “potentially unsafe levels” of total yeast and mold and Aspergillus were found in a batch of cannabis flower.
